Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Aravive, Inc. ARAV |
Baker Bros. Advisors LP | 3,863,568 4.990% |
-722,836 (-15.76%) |
Filing History |
| 2024-02-14 10:24 am Purchase |
2023-12-31 | 13G | Aravive, Inc. ARAV |
BIOTECHNOLOGY VALUE FUND L P | 8,164,510 9.990% |
2,055,452 (+33.65%) |
Filing History |
| 2024-02-09 5:14 pm Sale |
2023-12-31 | 13G | Aravive, Inc. ARAV |
Artal Participations S.a r.l | 7,609,522 9.400% |
-4,572,515 (-37.53%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Aravive, Inc. ARAV |
Baker Bros. Advisors LP | 4,586,404 7.500% |
4,586,404 (New Position) |
Filing History |
| 2023-02-10 7:28 pm Purchase |
2022-12-31 | 13G | Aravive, Inc. ARAV |
Artal Participations S.a r.l | 12,182,037 9.900% |
10,870,746 (+829.01%) |
Filing History |
| 2022-12-28 4:00 pm Purchase |
2022-10-27 | 13D | Aravive, Inc. ARAV |
Zhang Eric | 2,029,634 3.400% |
1,169,868 (+136.07%) |
Filing History |
| 2022-12-27 4:05 pm Purchase |
2022-10-27 | 13D | Aravive, Inc. ARAV |
Giaccia Amato | 1,725,244 2.900% |
546,932 (+46.42%) |
Filing History |
| 2022-11-07 4:50 pm Purchase |
2022-10-27 | 13G | Aravive, Inc. ARAV |
BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.990% |
6,109,058 (New Position) |
Filing History |
| 2022-11-03 4:45 pm Purchase |
2022-10-24 | 13D | Aravive, Inc. ARAV |
Eshelman Ventures LLC | 26,451,103 43.600% |
26,451,103 (New Position) |
Filing History |
| 2022-04-05 4:15 pm Purchase |
2022-03-29 | 13D | Aravive, Inc. ARAV |
ESHELMAN FREDRIC N | 10,111,882 34.000% |
5,806,201 (+134.85%) |
Filing History |
| 2022-02-11 4:48 pm Unchanged |
2021-12-31 | 13G | Aravive, Inc. ARAV |
New Leaf Biopharma Opportunities II L.P. | 946,423 4.500% |
0 (Unchanged) |
Filing History |
| 2022-01-05 6:32 pm Purchase |
2022-01-03 | 13D | Aravive, Inc. ARAV |
ESHELMAN FREDRIC N | 4,305,681 19.990% |
472,828 (+12.34%) |
Filing History |
| 2021-04-15 07:00 am Sale |
2021-04-12 | 13D | Aravive, Inc. ARAV |
Tabibiazar Raymond | 1,606,511 7.900% |
-29,074 (-1.78%) |
Filing History |
| 2021-03-23 07:05 am Purchase |
2021-03-19 | 13D | Aravive, Inc. ARAV |
Giaccia Amato | 1,178,312 5.900% |
15,704 (+1.35%) |
Filing History |
| 2021-02-18 7:55 pm Sale |
2020-04-22 | 13D | Aravive, Inc. ARAV |
Liu Qianye | 449,910 2.800% |
-409,856 (-47.67%) |
Filing History |
| 2021-02-18 7:00 pm Purchase |
2021-02-12 | 13D | Aravive, Inc. ARAV |
ESHELMAN FREDRIC N | 3,832,853 19.800% |
2,901,755 (+311.65%) |
Filing History |
| 2021-02-12 8:45 pm Sale |
2020-12-31 | 13G | Aravive, Inc. ARAV |
Artal Participations S.a r.l | 1,311,291 8.200% |
-38,709 (-2.87%) |
Filing History |